Colgate-Palmolive (CL) Projected to Post Earnings on Friday

Colgate-Palmolive (NYSE:CL) is projected to release its Q4 2025 results before the market opens on Friday, January 30th. Analysts expect Colgate-Palmolive to post earnings of $0.92 per share and revenue of $5.1288 billion for the quarter. Parties can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Friday, January 30, 2026 at 8:30 AM ET.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, October 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.89 by $0.02. Colgate-Palmolive had a net margin of 14.47% and a return on equity of 333.39%. The firm had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.17 billion. During the same quarter in the prior year, the business posted $0.91 EPS. The business’s revenue was up 1.9% compared to the same quarter last year. On average, analysts expect Colgate-Palmolive to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Colgate-Palmolive Stock Up 1.2%

Shares of CL opened at $85.78 on Friday. The company has a current ratio of 0.93, a quick ratio of 0.60 and a debt-to-equity ratio of 5.90. Colgate-Palmolive has a 12 month low of $74.54 and a 12 month high of $100.18. The firm’s 50 day moving average is $79.89 and its 200-day moving average is $81.62. The stock has a market capitalization of $69.14 billion, a PE ratio of 24.03, a P/E/G ratio of 5.74 and a beta of 0.30.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st will be paid a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date is Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is 58.26%.

Analysts Set New Price Targets

CL has been the subject of several analyst reports. Evercore ISI dropped their price objective on Colgate-Palmolive from $100.00 to $94.00 and set an “outperform” rating for the company in a report on Monday, November 3rd. Weiss Ratings restated a “hold (c)” rating on shares of Colgate-Palmolive in a research report on Wednesday, October 8th. Raymond James Financial dropped their price target on Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating for the company in a research note on Monday, October 20th. Bank of America reduced their price objective on shares of Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating on the stock in a research note on Wednesday, October 8th. Finally, JPMorgan Chase & Co. raised their target price on shares of Colgate-Palmolive from $88.00 to $93.00 and gave the company an “overweight” rating in a report on Friday, January 16th. Eleven investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $89.44.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the business. Brighton Jones LLC lifted its holdings in shares of Colgate-Palmolive by 4.4% in the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock worth $962,000 after acquiring an additional 450 shares during the last quarter. Woodline Partners LP increased its position in Colgate-Palmolive by 76.3% during the 1st quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock worth $4,344,000 after purchasing an additional 20,062 shares in the last quarter. Schnieders Capital Management LLC. lifted its stake in Colgate-Palmolive by 2.0% in the 2nd quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company’s stock valued at $1,136,000 after purchasing an additional 245 shares during the last quarter. Nebula Research & Development LLC lifted its stake in Colgate-Palmolive by 165.5% in the 2nd quarter. Nebula Research & Development LLC now owns 10,326 shares of the company’s stock valued at $939,000 after purchasing an additional 6,437 shares during the last quarter. Finally, Sei Investments Co. boosted its position in Colgate-Palmolive by 21.7% in the second quarter. Sei Investments Co. now owns 657,093 shares of the company’s stock valued at $59,732,000 after buying an additional 116,968 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.